Keyword: Watson Pharmaceuticals
News
24.07.2013
- A U.S. Supreme Court ruling giving regulators the right to sue drugmakers for agreements that delay sale of cheaper generic pharmaceuticals should deter some of the most egregious...
News
17.04.2013
- Pharmaceutical company Actavis said on Tuesday that it would once again sell a generic version of Bayer's Yaz after an appeals court ruled that Bayer's patent for the oral...
News
23.03.2013
- The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...
News
05.03.2013
- U.S. regulators granted Pfizer a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on...
News
19.10.2012
- Actavis, the Swiss generic drugmaker that Watson Pharmaceuticals is taking over, said revenue would rise to more than €2 billion ($2.6 billion) this year, driven by patent expiries...
News
16.10.2012
- Watson Pharmaceuticals has won U.S. antitrust approval to buy Swiss peer Actavis on the condition that it sell a number of their current and future products to two other companies...
News
15.10.2012
- The U.S. Supreme Court on Monday rejected Allergans appeal of a ruling that favored generic drugmaker Watson Pharmaceuticals over patents related to the treatment of an overactive...
News
05.10.2012
- The Federal Trade Commission asked the US Supreme Court on Thursday to take up its fight against deals between brand-name drug companies and generic firms which they say delay the...
